Biological medicines are an important advancement in the pharmaceutical...
January 2020
These guidelines have been produced by PHARMAC in conjunction...
July 2018
From 1 August, 2018, rivaroxaban will be fully subsidised without...
July 2018
Intravenous ferric carboxymaltose is now a potential option...
November 2017
Most patients with atrial fibrillation can be managed in primary...
August 2017
Patients taking oral anticoagulants require appropriate management...
August 2017
The risks and benefits of treatment with inhaled corticosteroids...
March 2016
Hereditary haemochromatosis is the most common genetic disease...
April 2015
This report provides an update on the use and monitoring of...
March 2015
The New Zealand Laboratory Schedule has been created to provide...
August 2014
2013 UPDATE: Investigating iron deficiency anaemia
December 2013
A finding of anaemia on a full blood count is only the first...
September 2013
Ticagrelor (Brilinta) is a new oral antiplatelet medicine, which...
August 2013
Dabigatran is an oral anticoagulant approved for use in non-valvular...
March 2013
Dabigatran has been available for general practitioners to prescribe...
February 2013
Glandular fever (infectious mononucleosis) is a common, potentially...
October 2012
Atrial fibrillation (AF) is often an incidental finding during...
October 2011
In July 2011, a consensus forum was held in Wellington to discuss...
October 2011
Dabigatran (Pradaxa) is now available in New Zealand, fully...
September 2011
Interpreting and managing a laboratory result of abnormal sodium...
September 2011
Dabigatran to be listed | Most broad spectrum antibiotics do...
June 2011
Testing for thrombophilia is rarely indicated in general practice...
March 2011
Regular measurement of INR levels is an essential component...
November 2010
Clopidogrel, an antiplatelet medicine, is now able to be prescribed...
October 2010
The international normalised ratio (INR) is used to monitor...
October 2010
Evidence suggests that warfarin is under utilised in older people....
October 2010
The aim of stroke rehabilitation is for the patient to regain...
April 2010
Stroke is the third most common cause of death in New Zealand,...
March 2010
People who have had a stroke or transient ischaemic attack are...
March 2010
There are a number of causes of low vitamin B12 levels with...
March 2010
Should aspirin still be used for primary prevention of cardiovascular...
December 2009
Enoxaparin (Clexane) is a low molecular weight heparin used...
November 2009
A guide focusing on some of the situations GPs face in day-to-day...
July 2009
Report on testing for Hepatitis A and B.
July 2009
Antiplatelet drugs including aspirin, clopidogrel and dipyrimadole,...
February 2009
The decision whether to choose aspirin or warfarin for stroke...
February 2009
Provides an overview of the use of the complete blood count...
May 2008
Is there an association between the use of the combined oral...
April 2007
Warfarin has the potential to interact with numerous drugs resulting...
April 2007
SSRIs can increase the risk of bleeding disorders, especially...
December 2006
An update on treatment of atrial fibrillation with a focus on...
December 2006
